RevealDx

Healthcare Software · Washington, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1800 Westlake Ave N Ste 104, Seattle, Wa...

Revenue

<$5 Million

Industry

Healthcare Software Software
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About RevealDx

Reveal DX is a Seattle-based software company focused on improving lung cancer outcomes through non-invasive diagnosis. They offer advanced, AI-enabled decision support software for lung cancer, which includes a Malignancy Similarity Index (mSI) to assist clinicians in assessing lung nodules. Their technology aims to reduce unnecessary procedures and associated costs while enhancing diagnostic confidence. Reveal DX's products have received FDA clearance and are authorized for clinical use in multiple jurisdictions.Explore more
Popular SearchesRevealDxSIC Code 73,737NAICS Code 51,513Show more

RevealDx Org Chart

PhoneEmail
MC
United States flag for contact location.

Chief Technology Officer & Head of Product

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is RevealDx your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

RevealDx News & Media

Read more news

Top Healthcare Software Companies

Frequently Asked Questions Regarding RevealDx

What is RevealDx's official website?
RevealDx's official website is www.reveal-dx.com
What is RevealDx's Revenue?
RevealDx's revenue is <$5 Million
What is RevealDx's SIC code?
RevealDx's SIC: 73,737
What is RevealDx's NAICS code?
RevealDx's NAICS: 51,513
How many employees does RevealDx have?
RevealDx has 11-50 employees
What industry does RevealDx belong to?
RevealDx is in the industry of: Healthcare Software, Software
Who is the CTO of RevealDx?
RevealDx's CTO is Michael Calhoun
What does RevealDx do?

Reveal DX is a Seattle-based software company focused on improving lung cancer outcomes through non-invasive diagnosis. They offer advanced, AI-enabled decision support software for lung cancer, which includes a Malignancy Similarity Index (mSI) to assist clinicians in assessing lung nodules. Their technology aims to reduce unnecessary procedures a... nd associated costs while enhancing diagnostic confidence. Reveal DX's products have received FDA clearance and are authorized for clinical use in multiple jurisdictions.Read More

Is RevealDx a public company?
RevealDx is private company therefore does not currently have an official ticker symbol
See more information about RevealDx

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.